MTOR and melanoma: Further, the alterations in major components of the mTOR pathway like loss of function of PTEN, PI3K amplification/mutation and over-expression of S6K1, 4EBP1, eIF4E and AKT have been reported to be associated with many types of cancers, particularly in melanoma and glioblastama [55,56].